Aug 2026· Die Innere Medizin· Vol 67, pp. 1063 - 1072· 0 citations· 20 references
Medicine
TL;DR
A practice-oriented evaluation of the indications, clinical benefits, and safety of modern diabetes technologies and suggests that technologies should be offered according to individual needs, abilities, preferences, and life circumstances and implemented early, including at the time of diagnosis.
Randomized and real-world studies demonstrate that AID systems significantly improve A1C and time in range while minimizing hypoglycemia, without increasing treatment complexity or patient burden, and position AID as a practical and effective strategy to overcome long-standing therapeutic inertia in type 2 diabetes.
Z. Tariq, Grazia Aleppo, Anders L. Carlson et al.· Endocrine Practice· 0 citations
Continuation of insulin pumps was associated with improvement in hyperglycemia without increased hypoglycemia risk and with shorter LOS in the hospital and standardized institutional policies may help expand safe continuation of AID during hospitalizations.
Kathleen R Ruddiman, J. Evans, Joseph A. Aloi et al.· Journal of Diabetes Science...· 0 citations
CGM is safe in very young children, with AID systems proving superior to traditional therapy, and real-world evidence supports incorporating AID consideration into future international guidelines from the time of pediatric diagnosis.
M. Marigliano, A. Scaramuzza, C. Arnaldi et al.· Diabetes Technology & Therap...· 0 citations
INTRODUCTION
Clinical inertia and the complexity of basal insulin titration are major barriers to optimal glycemic control in adults with type 2 diabetes (T2D). A prototype of the Dexcom Smart Basal system known as basal therapy optimization (BTO), a continuous glucose monitoring (CGM)-informed basal insulin optimizati...
S. Oser, C. Crystal, K. Hames et al.· Diabetes Therapy· 0 citations
The successful management of type-1 diabetes (T1D) and insulin-dependent type-2 diabetes depends on the ability to accurately calibrate bolus and basal insulin doses, and minimize the time spent with high postprandial blood glucose (BG) levels while avoiding dangerously low hypoglycemic excursions. Precise calibration...
I. Aganj, N. Bryant, Leah (Morgan) Panaro et al.· medRxiv· 0 citations
In recent years, continuous glucose monitoring (CGM) systems have become increasingly common and more widely available for people with diabetes. A variety of devices appearing on the market, together with their increasing integration with other tools (insulin pumps, watches, and smartphone applications), require medica...
Oskar Kublin, D. Filipowicz, Mariusz Stępień· Archives of Medical Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
